Adenosine receptor agonists modulate visceral hyperalgesia in the rat

Area of Science:

• Neuroscience
• Pharmacology
• Pain Research

Background:

• Adenosine is an endogenous modulator of nociception.
• The role of adenosine in visceral hyperalgesia is not well understood.
• This study investigates adenosine receptor agonists in a visceral hyperalgesia model.

Purpose of the Study:

• To determine the effects of adenosine receptor agonists on visceral hyperalgesia.
• To evaluate the potential of specific adenosine receptor subtypes in pain modulation.
• To assess the dose-dependent effects and side effects of these agonists.

Main Methods:

• Visceromotor response (VMR) to colorectal distension (CRD) was measured in rats.
• Visceral hyperalgesia was induced by intracolonic zymosan administration.
• Adenosine receptor agonists were administered subcutaneously or intrathecally.

Main Results:

• Subcutaneous agonists (NECA, R-PIA, CGS-21680) attenuated VMR but caused hindlimb weakness at high doses.
• Intrathecal NECA and R-PIA dose-dependently reduced VMR.
• Intrathecal CGS-21680 was ineffective, and high-dose NECA caused motor weakness.

Conclusions:

• Adenosine receptor agonists show antihyperalgesic effects but can cause motor weakness.
• Spinal A1 receptor activation significantly reduces VMR without motor impairment.
• Targeting spinal A1 receptors may be a viable strategy for treating visceral hyperalgesia.